2,162 XNAS Volume
XNAS 28 Feb, 2025 4:30 PM (EST)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| N. Albert Marchio | Director, CEO and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Dec 2023 | 1,250 | 0 | - | - | Restricted Stock Units | |
| Aaron Fox-Collis | VP of Finance & CAO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Dec 2023 | 8,000 | 0 | - | - | Restricted Stock Units | |
| Aaron Fox-Collis | VP of Finance & CAO | Sale of securities on an exchange or to another person at price $ 0.91 per share. | 08 Dec 2023 | 74 | 0 (0%) | 0% | 0.9 | 67 | Common Stock |
| Aaron Fox-Collis | VP of Finance & CAO | Sale of securities on an exchange or to another person at price $ 0.86 per share. | 04 Dec 2023 | 36 | 74 (0%) | 0% | 0.9 | 31 | Common Stock |
| Deepak Chadha | Former Chief R&D Officer & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 35,000 | 0 | - | - | Restricted Stock Units | |
| Chadha Deepak | Former Chief R&D Officer & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 01 Sep 2023 | 14,978 | 22,314 (0%) | 0% | 0.6 | 9,301 | Common Stock |
| Deepak Chadha | Former Chief R&D Officer & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 35,000 | 37,292 (0%) | 0% | - | Common Stock | |
| Albert N. Marchio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 1,250 | 1,250 | - | - | Restricted Stock Units | |
| Deepak Chadha | Chief R&D Officer and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 35,000 | 35,000 | - | - | Restricted Stock Units | |
| David R. McAvoy | Gen Counsel, CCO, & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| Andrew D. Sklawer | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 55,000 | 55,000 | - | - | Restricted Stock Units | |
| Gary A. Lyons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
| Vijay B. Samant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
| Reginald L. Hardy | Director, CHAIRMAN OF THE BOARD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
| Albert N. Marchio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Deepak Chadha | Chief Research & Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 325,000 | 325,000 | - | - | Stock Option (right to buy) | |
| Monica E. Luchi | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 325,000 | 325,000 | - | - | Stock Option (right to buy) | |
| David R. McAvoy | General Counsel and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| Robert Busard Brown | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 1,100,000 | 1,100,000 | - | - | Stock Option (right to buy) | |
| Andrew D. Sklawer | COO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 450,000 | 450,000 | - | - | Stock Option (right to buy) | |
| Jose Breton | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Reginald L. Hardy | Director, CHAIRMAN OF THE BOARD | Purchase of securities on an exchange or from another person at price $ 0.66 per share. | 23 Jul 2021 | 100,000 | 348,411 (3%) | 1% | 0.7 | 66,230 | Common Stock |
| Reginald L. Hardy | Director, CHAIRMAN OF THE BOARD | Purchase of securities on an exchange or from another person at price $ 0.67 per share. | 23 Jul 2021 | 100,000 | 448,411 (4%) | 1% | 0.7 | 67,420 | Common Stock |
| David R. McAvoy | General Counsel and CCO | Purchase of securities on an exchange or from another person at price $ 0.67 per share. | 23 Jul 2021 | 18,124 | 128,879 (1%) | 0% | 0.7 | 12,138 | Common Stock |
| Albert N. Marchio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Gary A. Lyons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Vijay B. Samant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Reginald L. Hardy | Director, CHAIRMAN OF THE BOARD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Deepak Chadha | Chief Research & Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| David R. McAvoy | General Counsel and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Robert Busard Brown | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 750,000 | 750,000 | - | - | Stock Option (right to buy) | |
| Andrew D. Sklawer | COO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Jose Breton | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 85,000 | 85,000 | - | - | Stock Option (right to buy) | |
| Deepak Chadha | Chief Research & Dev. Officer | Purchase of securities on an exchange or from another person at price $ 0.82 per share. | 18 May 2021 | 2,700 | 65,667 (0%) | 0% | 0.8 | 2,212 | Common Stock |
| Deepak Chadha | Chief Research & Dev. Officer | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 18 May 2021 | 12,500 | 78,167 (0%) | 0% | 0.8 | 10,378 | Common Stock |
| David R. McAvoy | General Counsel and CCO | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 17 May 2021 | 18,622 | 110,755 (1%) | 0% | 0.8 | 14,898 | Common Stock |
| David R. McAvoy | General Counsel and CCO | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 17 May 2021 | 7,980 | 13,980 (0%) | 0% | 0.8 | 6,384 | Common Stock |
| Andrew D. Sklawer | COO and Secretary | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 17 May 2021 | 15,375 | 124,625 (1%) | 0% | 0.8 | 12,300 | Common Stock |
| Deepak Chadha | Chief Research & Dev. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 25,000 | 71,717 (0%) | 0% | - | Common Stock | |
| Deepak Chadha | Chief Research & Dev. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 25,000 | 0 | - | - | Restricted Stock Units | |
| Deepak Chadha | Chief Research & Dev. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 16 Mar 2021 | 8,750 | 62,967 (0%) | 0% | 1.1 | 9,975 | Common Stock |
| David R. McAvoy | General Counsel and CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 16 Mar 2021 | 8,750 | 92,133 (0%) | 0% | 1.1 | 9,975 | Common Stock |
| David R. McAvoy | General Counsel and CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 25,000 | 0 | - | - | Restricted Stock Units | |
| David R. McAvoy | General Counsel and CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 25,000 | 100,883 (1%) | 0% | - | Common Stock | |
| Andrew D. Sklawer | COO and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 16 Mar 2021 | 7,000 | 109,250 (1%) | 0% | 1.1 | 7,980 | Common Stock |
| Andrew D. Sklawer | COO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 20,000 | 0 | - | - | Restricted Stock Units | |
| Andrew D. Sklawer | COO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 20,000 | 116,250 (1%) | 0% | - | Common Stock | |
| Jose Breton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 16 Mar 2021 | 5,250 | 11,919 (0%) | 0% | 1.1 | 5,985 | Common Stock |
| Jose Breton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 15,000 | 0 | - | - | Restricted Stock Units | |
| Jose Breton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 15,000 | 17,169 (0%) | 0% | - | Common Stock | |
| Robert Busard Brown | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 15 Mar 2021 | 100,000 | 186,957 (1%) | 1% | 1.2 | 117,780 | Common Stock |
| David R. McAvoy | General Counsel and CCO | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 18 Sep 2020 | 16,526 | 75,883 (0%) | 0% | 0.8 | 13,713 | Common Stock |
| David R. McAvoy | General Counsel and CCO | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 18 Sep 2020 | 6,000 | 6,000 (0%) | 0% | 0.8 | 5,039 | Common Stock |
| Gary A. Lyons | Director | Grant, award, or other acquisition of securities at price $ 0.81 per share. | 15 Sep 2020 | 11,934 | 24,729 (0%) | 0% | 0.8 | 9,667 | Common Stock |
| Gary A. Lyons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Vijay B. Samant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Vijay B. Samant | Director | Grant, award, or other acquisition of securities at price $ 0.81 per share. | 15 Sep 2020 | 10,493 | 23,542 (0%) | 0% | 0.8 | 8,499 | Common Stock |
| Reginald L. Hardy | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.81 per share. | 15 Sep 2020 | 15,226 | 205,849 (2%) | 0% | 0.8 | 12,333 | Common Stock |
| Reginald L. Hardy | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Deepak Chadha | Chief Research & Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| David R. McAvoy | General Counsel and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 350,000 | 350,000 | - | - | Stock Option (right to buy) | |
| Robert Busard Brown | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 1,000,000 | 1,000,000 | - | - | Stock Option (right to buy) | |
| Andrew D. Sklawer | COO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 450,000 | 450,000 | - | - | Stock Option (right to buy) | |
| Jose Breton | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Gary A. Lyons | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. | 31 Aug 2020 | 346 | 21,426 (0%) | 0% | 0.9 | 325 | Common Stock |
| Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2020 | 692 | 0 | - | - | Restricted Stock Units | |
| Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2020 | 692 | 21,772 (0%) | 0% | - | Common Stock | |
| Gary A. Lyons | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. | 31 Aug 2020 | 8,631 | 12,795 (0%) | 0% | 0.9 | 8,113 | Common Stock |
| Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2020 | 609 | 0 | - | - | Restricted Stock Units | |
| Vijay B. Samant | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. | 31 Aug 2020 | 6,375 | 13,049 (0%) | 0% | 0.9 | 5,993 | Common Stock |
| Vijay B. Samant | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. | 31 Aug 2020 | 256 | 19,424 (0%) | 0% | 0.9 | 241 | Common Stock |
| Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2020 | 609 | 19,680 (0%) | 0% | - | Common Stock | |
| Reginald L. Hardy | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2020 | 883 | 197,954 (2%) | 0% | - | Common Stock | |
| Reginald L. Hardy | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2020 | 883 | 0 | - | - | Restricted Stock Units | |
| Reginald L. Hardy | Director, Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. | 31 Aug 2020 | 283 | 197,671 (2%) | 0% | 0.9 | 266 | Common Stock |
| Reginald L. Hardy | Director, Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. | 31 Aug 2020 | 7,048 | 190,623 (1%) | 0% | 0.9 | 6,625 | Common Stock |
| Gary A. Lyons | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.92 per share. | 31 Jul 2020 | 346 | 21,080 (0%) | 0% | 0.9 | 318 | Common Stock |
| Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2020 | 692 | 21,426 (0%) | 0% | - | Common Stock | |
| Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2020 | 692 | 692 | - | - | Restricted Stock Units | |
| Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2020 | 608 | 19,327 (0%) | 0% | - | Common Stock | |
| Vijay B. Samant | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.92 per share. | 31 Jul 2020 | 256 | 19,071 (0%) | 0% | 0.9 | 236 | Common Stock |
| Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2020 | 608 | 609 | - | - | Restricted Stock Units | |
| Reginald L. Hardy | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2020 | 882 | 883 | - | - | Restricted Stock Units | |
| Reginald L. Hardy | Director, Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.92 per share. | 31 Jul 2020 | 283 | 197,071 (2%) | 0% | 0.9 | 260 | Common Stock |
| Reginald L. Hardy | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2020 | 882 | 197,354 (2%) | 0% | - | Common Stock | |
| Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2020 | 691 | 1,384 | - | - | Restricted Stock Units | |
| Gary A. Lyons | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.00 per share. | 30 Jun 2020 | 346 | 20,734 (0%) | 0% | 1 | 346 | Common Stock |
| Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2020 | 691 | 21,080 (0%) | 0% | - | Common Stock | |
| Vijay B. Samant | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.00 per share. | 30 Jun 2020 | 256 | 18,719 (0%) | 0% | 1 | 256 | Common Stock |
| Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2020 | 608 | 1,217 | - | - | Restricted Stock Units | |
| Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2020 | 608 | 18,975 (0%) | 0% | - | Common Stock | |
| Reginald L. Hardy | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2020 | 883 | 1,765 | - | - | Restricted Stock Units | |
| Reginald L. Hardy | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2020 | 883 | 196,755 (2%) | 0% | - | Common Stock | |
| Reginald L. Hardy | Director, Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.00 per share. | 30 Jun 2020 | 283 | 196,472 (2%) | 0% | 1 | 283 | Common Stock |
| Deepak Chadha | Chief Research & Dev. Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2020 | 26,087 | 46,717 (0%) | 0% | - | Common Stock | |
| Deepak Chadha | Chief Research & Dev. Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2020 | 26,087 | 26,087 | - | - | Common Stock Warrants (right to buy) | |
| David R. McAvoy | General Counsel and CCO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2020 | 30,435 | 59,357 (0%) | 0% | - | Common Stock | |
| David R. McAvoy | General Counsel and CCO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2020 | 30,435 | 30,435 | - | - | Common Stock Warrants (right to buy) | |
| Robert Busard Brown | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2020 | 86,957 | 86,957 | - | - | Common Stock Warrants (right to buy) | |
| Robert Busard Brown | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2020 | 86,957 | 86,957 (0%) | 0% | - | Common Stock | |
| Andrew D. Sklawer | COO and Secretary | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2020 | 13,044 | 13,044 | - | - | Common Stock Warrants (right to buy) | |
| Andrew D. Sklawer | COO and Secretary | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2020 | 13,044 | 96,250 (0%) | 0% | - | Common Stock | |
| R. Michael Carruthers | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2020 | 10,000 | 10,000 | - | - | Restricted Stock Units | |
| Deepak Chadha | Chief Research & Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2020 | 25,000 | 25,000 | - | - | Restricted Stock Units | |
| Adam S. Levy | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2020 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| David R. McAvoy | General Counsel and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2020 | 25,000 | 25,000 | - | - | Restricted Stock Units | |
| Andrew D. Sklawer | COO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2020 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| Jose Breton | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2020 | 15,000 | 15,000 | - | - | Restricted Stock Units | |
| Gary A. Lyons | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. | 14 Feb 2020 | 346 | 2,091 (0%) | 0% | 2.9 | 1,014 | Common Stock |
| Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 692 | 2,437 (0%) | 0% | - | Common Stock | |
| Gary A. Lyons | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. | 14 Feb 2020 | 1,746 | 1,745 (0%) | 0% | 1.2 | 2,025 | Common Stock |
| Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 3,491 | 3,491 (0%) | 0% | - | Common Stock | |
| Gary A. Lyons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2020 | 2,167 | 2,167 | - | - | Stock Options | |
| Gary A. Lyons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2020 | 8,333 | 8,333 | - | - | Restricted Stock Units | |
| Gary A. Lyons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2020 | 4,333 | 4,333 | - | - | Stock Option (right to buy) | |
| Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 692 | 692 | - | - | Restricted Stock Units | |
| Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 692 | 692 | - | - | Restricted Stock Units | |
| Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 691 | 691 | - | - | Restricted Stock Units | |
| Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 692 | 692 | - | - | Restricted Stock Units | |
| Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 3,491 | 3,491 | - | - | Restricted Stock Units | |
| Gary A. Lyons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2020 | 17,261 | 20,389 (0%) | 0% | 0 | Common Stock | |
| Gary A. Lyons | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. | 14 Feb 2020 | 346 | 3,128 (0%) | 0% | 1.2 | 401 | Common Stock |
| Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 692 | 3,474 (0%) | 0% | - | Common Stock | |
| Gary A. Lyons | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 14 Feb 2020 | 346 | 2,782 (0%) | 0% | 1.2 | 415 | Common Stock |
| Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 692 | 3,128 (0%) | 0% | - | Common Stock | |
| Gary A. Lyons | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share. | 14 Feb 2020 | 346 | 2,436 (0%) | 0% | 1.2 | 412 | Common Stock |
| Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 691 | 2,782 (0%) | 0% | - | Common Stock | |
| Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 3,070 | 3,070 | - | - | Restricted Stock Units | |
| Vijay B. Samant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2020 | 2,167 | 2,167 | - | - | Stock Options | |
| Vijay B. Samant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2020 | 7,328 | 7,328 | - | - | Restricted Stock Units | |
| Vijay B. Samant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2020 | 4,333 | 4,333 | - | - | Stock Option (right to buy) | |
| Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 608 | 608 | - | - | Restricted Stock Units | |
| Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 609 | 609 | - | - | Restricted Stock Units | |
| Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 608 | 608 | - | - | Restricted Stock Units | |
| Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 608 | 608 | - | - | Restricted Stock Units | |
| Vijay B. Samant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2020 | 15,178 | 18,367 (0%) | 0% | 0 | Common Stock | |
| Vijay B. Samant | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. | 14 Feb 2020 | 256 | 3,189 (0%) | 0% | 1.2 | 297 | Common Stock |
| Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 608 | 3,445 (0%) | 0% | - | Common Stock | |
| Vijay B. Samant | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 14 Feb 2020 | 256 | 2,837 (0%) | 0% | 1.2 | 307 | Common Stock |
| Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 609 | 3,093 (0%) | 0% | - | Common Stock | |
| Vijay B. Samant | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share. | 14 Feb 2020 | 256 | 2,484 (0%) | 0% | 1.2 | 305 | Common Stock |
| Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 608 | 2,740 (0%) | 0% | - | Common Stock | |
| Vijay B. Samant | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. | 14 Feb 2020 | 256 | 2,132 (0%) | 0% | 2.9 | 750 | Common Stock |
| Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 608 | 2,388 (0%) | 0% | - | Common Stock | |
| Vijay B. Samant | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. | 14 Feb 2020 | 1,290 | 1,780 (0%) | 0% | 1.2 | 1,496 | Common Stock |
| Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 3,070 | 3,070 (0%) | 0% | - | Common Stock | |
| Reginald L. Hardy | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 4,454 | 172,877 (1%) | 0% | - | Common Stock | |
| Reginald L. Hardy | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2020 | 5,333 | 5,333 | - | - | Stock Option (right to buy) | |
| Reginald L. Hardy | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 882 | 882 | - | - | Restricted Stock Units | |
| Reginald L. Hardy | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2020 | 10,632 | 10,632 | - | - | Restricted Stock Units | |
| Reginald L. Hardy | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 883 | 883 | - | - | Restricted Stock Units | |
| Reginald L. Hardy | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 882 | 882 | - | - | Restricted Stock Units | |
| Reginald L. Hardy | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 883 | 883 | - | - | Restricted Stock Units | |
| Reginald L. Hardy | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 4,454 | 4,454 | - | - | Restricted Stock Units | |
| Reginald L. Hardy | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2020 | 22,023 | 195,872 (2%) | 0% | 0 | Common Stock | |
| Reginald L. Hardy | Director, Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. | 14 Feb 2020 | 283 | 173,849 (1%) | 0% | 1.2 | 328 | Common Stock |
| Reginald L. Hardy | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 882 | 174,132 (1%) | 0% | - | Common Stock | |
| Reginald L. Hardy | Director, Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 14 Feb 2020 | 283 | 173,250 (1%) | 0% | 1.2 | 340 | Common Stock |
| Reginald L. Hardy | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 883 | 173,533 (1%) | 0% | - | Common Stock | |
| Reginald L. Hardy | Director, Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share. | 14 Feb 2020 | 283 | 172,650 (1%) | 0% | 1.2 | 337 | Common Stock |
| Reginald L. Hardy | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 882 | 172,933 (1%) | 0% | - | Common Stock | |
| Reginald L. Hardy | Director, Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. | 14 Feb 2020 | 283 | 172,051 (1%) | 0% | 2.9 | 829 | Common Stock |
| Reginald L. Hardy | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2020 | 2,667 | 2,667 | - | - | Stock Options | |
| Reginald L. Hardy | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 883 | 172,334 (1%) | 0% | - | Common Stock | |
| Reginald L. Hardy | Director, Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. | 14 Feb 2020 | 1,426 | 171,451 (1%) | 0% | 1.2 | 1,654 | Common Stock |
| George B. Abercrombie | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2020 | 8,764 | 8,764 | - | - | Stock Options | |
| George B. Abercrombie | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2020 | 2,167 | 2,167 | - | - | Restricted Stock Units | |
| Sanjeev Ahuja | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2019 | 83,313 | 83,313 | - | - | Stock Options | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2018 | 105,000 | 105,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2018 | 6,500 | 6,500 | - | - | Nonstatutory Stock Option (right to buy) | |
| R. Gordon Douglas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2018 | 8,000 | 8,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Thomas E. Shenk | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2018 | 6,500 | 6,500 | - | - | Nonstatutory Stock Option (right to buy) | |
| George J. Morrow | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2018 | 6,500 | 6,500 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert C. Merton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2018 | 6,500 | 6,500 | - | - | Nonstatutory Stock Option (right to buy) | |
| Richard M. Beleson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2018 | 6,500 | 6,500 | - | - | Nonstatutory Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2018 | 36,775 | 36,775 | - | - | Nonstatutory Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2018 | 68,225 | 68,225 | - | - | Employee Stock Option (right to buy) | |
| Larry Smith | Sr VP, Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2018 | 8,467 | 8,467 | - | - | Nonstatutory Stock Option (right to buy) | |
| Larry Smith | Sr VP, Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2018 | 51,533 | 51,533 | - | - | Employee Stock Option (right to buy) | |
| Anthony A. Ramos | VP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2018 | 14,562 | 14,562 | - | - | Nonstatutory Stock Option (right to buy) | |
| Anthony A. Ramos | VP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2018 | 55,438 | 55,438 | - | - | Employee Stock Option (right to buy) | |
| Mammen P. Mammen | Sr VP, Clinical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2018 | 57,158 | 57,158 | - | - | Employee Stock Option (right to buy) | |
| Mammen P. Mammen | Sr VP, Clinical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2018 | 12,842 | 12,842 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert C. Merton | None | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 10 Nov 2017 | 85,700 | 95,451 (0%) | 0% | 1.8 | 149,975 | Common Stock $.01 par value |
| Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 6,500 | 6,500 | - | - | Nonstatutory Stock Option (right to buy) | |
| R. Gordon Douglas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 8,000 | 8,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Thomas E. Shenk | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 6,500 | 6,500 | - | - | Nonstatutory Stock Option (right to buy) | |
| George J. Morrow | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 6,500 | 6,500 | - | - | Nonstatutory Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 25,000 | 25,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Larry Smith | Sr VP, Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 10,000 | 10,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert C. Merton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 6,500 | 6,500 | - | - | Nonstatutory Stock Option (right to buy) | |
| Anthony A. Ramos | VP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 10,000 | 10,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Richard M. Beleson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 6,500 | 6,500 | - | - | Nonstatutory Stock Option (right to buy) | |
| Mammen P. Mammen | Sr VP, Clinical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 10,000 | 10,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 2.17 per share. | 27 Mar 2017 | 4,250 | 9,674 (0%) | 0% | 2.2 | 9,240 | Common Stock $.01 par value |
| Larry Smith | VP, Vaccine Research | Sale of securities on an exchange or to another person at price $ 2.31 per share. | 15 Mar 2017 | 875 | 17,696 (0%) | 0% | 2.3 | 2,021 | Common Stock $.01 par value |
| Larry Smith | VP, Vaccine Research | Sale of securities on an exchange or to another person at price $ 2.26 per share. | 10 Feb 2017 | 4,500 | 18,571 (0%) | 0% | 2.3 | 10,160 | Common Stock $.01 par value |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2017 | 21,854 | 50,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2017 | 28,146 | 28,146 | - | - | Employee Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2017 | 80,000 | 80,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Larry Smith | VP, Vaccine Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2017 | 25,000 | 25,000 | - | - | Employee Stock Option (right to buy) | |
| Larry Smith | VP, Vaccine Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2017 | 1,177 | 20,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Larry Smith | VP, Vaccine Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2017 | 18,823 | 18,823 | - | - | Employee Stock Option (right to buy) | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2017 | 787 | 20,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2017 | 25,000 | 25,000 | - | - | Employee Stock Option (right to buy) | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2017 | 19,213 | 19,213 | - | - | Employee Stock Option (right to buy) | |
| Larry Smith | VP, Vaccine Research | Sale of securities on an exchange or to another person at price $ 2.48 per share. | 11 Jan 2017 | 54 | 23,071 (0%) | 0% | 2.5 | 134 | Common Stock $.01 par value |
| Vijay B. Samant | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 2.45 per share. | 10 Jan 2017 | 5,763 | 91,170 (0%) | 0% | 2.4 | 14,114 | Common Stock $.01 par value |
| Robert C. Merton | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Dec 2016 | 2,000 | 9,751 | - | - | Common Stock $.01 par value | |
| Robert C. Merton | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Dec 2016 | 2,000 | 11,751 | - | - | Common Stock $.01 par value | |
| Robert C. Merton | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Dec 2016 | 2,327 | 15,751 | - | - | Common Stock $.01 par value | |
| Robert C. Merton | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Dec 2016 | 2,000 | 13,751 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Dec 2016 | 11,050 | 101,582 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Dec 2016 | 4,649 | 96,933 | - | - | Common Stock $.01 par value | |
| R. Gordon Douglas | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Dec 2016 | 10,078 | 10,828 | - | - | Common Stock $.01 par value | |
| Gary A. Lyons | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Dec 2016 | 7,078 | 7,828 | - | - | Common Stock $.01 par value | |
| Larry Smith | VP, Vaccine Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Oct 2016 | 54 | 23,125 | - | - | Common Stock $.01 par value | |
| Larry Smith | VP, Vaccine Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Jul 2016 | 54 | 23,179 | - | - | Common Stock $.01 par value | |
| Robert C. Merton | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Jun 2016 | 4,100 | 18,078 | - | - | Common Stock $.01 par value | |
| Robert C. Merton | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Jun 2016 | 4,900 | 13,978 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Jun 2016 | 15,700 | 112,632 | - | - | Common Stock $.01 par value | |
| R. Gordon Douglas | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 Jun 2016 | 10,078 | 20,906 | - | - | Common Stock $.01 par value | |
| Gary A. Lyons | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jun 2016 | 7,078 | 14,906 | - | - | Common Stock $.01 par value | |
| George J. Morrow | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2016 | 65,000 | 65,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2016 | 212,500 | 212,500 | - | - | Nonstatutory Stock Option (right to buy) | |
| Thomas E. Shenk | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2016 | 65,000 | 65,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2016 | 65,000 | 65,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| R. Gordon Douglas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2016 | 80,000 | 80,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert C. Merton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2016 | 65,000 | 65,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Richard M. Beleson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2016 | 65,000 | 65,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Larry Smith | VP, Vaccine Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2016 | 8,750 | 232,331 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Mar 2016 | 17,600 | 989,226 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Mar 2016 | 5,900 | 969,326 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Mar 2016 | 14,000 | 975,226 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Feb 2016 | 7,500 | 139,235 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 25 Jan 2016 | 193 | 146,735 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2016 | 225,756 | 225,756 | - | - | Employee Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2016 | 199,244 | 425,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Larry Smith | VP, Vaccine Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2016 | 20,071 | 250,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Larry Smith | VP, Vaccine Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2016 | 229,929 | 229,929 | - | - | Employee Stock Option (right to buy) | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2016 | 67,888 | 300,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2016 | 232,112 | 232,112 | - | - | Employee Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Jan 2016 | 48,535 | 1,018,028 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Jan 2016 | 11,202 | 1,006,826 | - | - | Common Stock $.01 par value | |
| Larry Smith | VP, Vaccine Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Jan 2016 | 974 | 241,081 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Jan 2016 | 75,000 | 1,066,563 | - | - | Common Stock $.01 par value | |
| Thomas E. Shenk | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2015 | 60,000 | 60,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Thomas E. Shenk | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2015 | 10,000 | 10,000 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 23 Oct 2015 | 193 | 146,928 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Oct 2015 | 4,738 | 1,141,563 | - | - | Common Stock $.01 par value | |
| Larry Smith | VP, Vaccine Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Oct 2015 | 974 | 242,055 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 23 Jul 2015 | 194 | 147,121 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 13 Jul 2015 | 4,737 | 1,146,301 | - | - | Common Stock $.01 par value | |
| Larry Smith | VP, Vaccine Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 13 Jul 2015 | 974 | 243,029 | - | - | Common Stock $.01 par value | |
| Igor Bilinsky | Sr VP, Corporate Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 13 Jul 2015 | 1,258 | 193,798 | - | - | Common Stock $.01 par value | |
| George J. Morrow | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 50,000 | 50,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| George J. Morrow | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 7,500 | 27,347 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 125,000 | 125,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Stephen A. Sherwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 50,000 | 50,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Stephen A. Sherwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 7,500 | 22,003 | - | - | Common Stock $.01 par value | |
| Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 50,000 | 50,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 7,500 | 78,281 | - | - | Common Stock $.01 par value | |
| R. Gordon Douglas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 65,000 | 65,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| R. Gordon Douglas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 7,500 | 108,281 | - | - | Common Stock $.01 par value | |
| Robert C. Merton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 50,000 | 50,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert C. Merton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 7,500 | 90,781 | - | - | Common Stock $.01 par value | |
| Richard M. Beleson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 50,000 | 50,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Richard M. Beleson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 7,500 | 22,078 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 23 Apr 2015 | 193 | 147,315 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 13 Apr 2015 | 4,738 | 1,151,038 | - | - | Common Stock $.01 par value | |
| Larry Smith | VP, Vaccine Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 13 Apr 2015 | 974 | 244,003 | - | - | Common Stock $.01 par value | |
| Igor Bilinsky | Sr VP, Corporate Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 13 Apr 2015 | 1,257 | 195,056 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Mar 2015 | 55,000 | 1,155,776 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Jan 2015 | 428 | 147,508 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2015 | 78,394 | 78,394 | - | - | Employee Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2015 | 171,606 | 250,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2015 | 300,000 | 1,210,776 | - | - | Common Stock $.01 par value | |
| Larry Smith | VP, Vaccine Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2015 | 67,500 | 67,500 | - | - | Employee Stock Option (right to buy) | |
| Larry Smith | VP, Vaccine Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2015 | 52,500 | 120,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Larry Smith | VP, Vaccine Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2015 | 70,000 | 244,977 | - | - | Common Stock $.01 par value | |
| Igor Bilinsky | Sr VP, Corporate Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2015 | 78,751 | 78,751 | - | - | Employee Stock Option (right to buy) | |
| Igor Bilinsky | Sr VP, Corporate Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2015 | 61,249 | 140,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Igor Bilinsky | Sr VP, Corporate Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2015 | 70,000 | 196,313 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2015 | 56,250 | 56,250 | - | - | Employee Stock Option (right to buy) | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2015 | 43,750 | 100,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2015 | 60,000 | 147,936 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 13 Jan 2015 | 4,737 | 910,776 | - | - | Common Stock $.01 par value | |
| Larry Smith | VP, Vaccine Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Jan 2015 | 1,912 | 174,977 | - | - | Common Stock $.01 par value | |
| Igor Bilinsky | Sr VP, Corporate Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Jan 2015 | 1,335 | 126,313 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Dec 2014 | 5,300 | 915,513 | - | - | Common Stock | |
| Vijay B. Samant | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Dec 2014 | 15,379 | 921,134 | - | - | Common Stock | |
| Vijay B. Samant | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Dec 2014 | 321 | 920,813 | - | - | Common Stock | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2014 | 175,000 | 175,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Oct 2014 | 428 | 87,936 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 13 Oct 2014 | 4,738 | 936,513 | - | - | Common Stock $.01 par value | |
| Larry Smith | VP, Vaccine Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 13 Oct 2014 | 1,912 | 176,889 | - | - | Common Stock $.01 par value | |
| Igor Bilinsky | Sr VP, Corporate Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 13 Oct 2014 | 1,335 | 127,648 | - | - | Common Stock $.01 par value | |
| Larry Smith | VP, Vaccine Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Aug 2014 | 12,500 | 178,801 | - | - | Common Stock $.01 par value | |
| Igor Bilinsky | Senior VP, Corporate Devt | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Aug 2014 | 12,500 | 128,983 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Aug 2014 | 12,500 | 88,364 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Jul 2014 | 428 | 100,864 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Jul 2014 | 4,737 | 941,251 | - | - | Common Stock $.01 par value | |
| Larry Smith | VP, Vaccine Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Jul 2014 | 1,912 | 191,301 | - | - | Common Stock $.01 par value | |
| Igor Bilinsky | Senior VP, Corporate Devt | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Jul 2014 | 1,335 | 141,483 | - | - | Common Stock $.01 par value | |
| George J. Morrow | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 50,000 | 50,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| George J. Morrow | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 7,500 | 19,847 | - | - | Common Stock $.01 par value | |
| Stephen A. Sherwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 50,000 | 50,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Stephen A. Sherwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 7,500 | 14,503 | - | - | Common Stock $.01 par value | |
| Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 50,000 | 50,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 7,500 | 70,781 | - | - | Common Stock $.01 par value | |
| R. Gordon Douglas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 65,000 | 65,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| R. Gordon Douglas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 7,500 | 100,781 | - | - | Common Stock $.01 par value | |
| Robert C. Merton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 50,000 | 50,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert C. Merton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 7,500 | 83,281 | - | - | Common Stock $.01 par value | |
| Richard M. Beleson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 50,000 | 50,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Richard M. Beleson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 7,500 | 14,578 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Apr 2014 | 428 | 101,292 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Apr 2014 | 4,738 | 945,988 | - | - | Common Stock $.01 par value | |
| Larry Smith | VP, Vaccine Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Apr 2014 | 1,912 | 193,213 | - | - | Common Stock $.01 par value | |
| Igor Bilinsky | Senior VP, Corporate Devt | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Apr 2014 | 1,150 | 142,818 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 23 Jan 2014 | 82 | 101,929 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 23 Jan 2014 | 209 | 101,720 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 19 Jan 2014 | 164 | 102,175 | - | - | Common Stock | |
| Anthony A. Ramos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 19 Jan 2014 | 164 | 102,011 | - | - | Common Stock | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2014 | 330,000 | 950,726 | - | - | Common Stock $.01 par value | |
| Larry Smith | VP, Vaccine Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2014 | 90,000 | 195,125 | - | - | Common Stock $.01 par value | |
| Igor Bilinsky | Senior VP, Corporate Devt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2014 | 90,000 | 143,968 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2014 | 70,000 | 102,339 | - | - | Common Stock $.01 par value | |
| Larry Smith | VP, Vaccine Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Jan 2014 | 655 | 107,422 | - | - | Common Stock $.01 par value | |
| Igor Bilinsky | Senior VP, Corporate Devt | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Jan 2014 | 54 | 55,692 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Nov 2013 | 7,918 | 32,339 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 23 Oct 2013 | 82 | 40,257 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 19 Oct 2013 | 163 | 40,502 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 19 Oct 2013 | 163 | 40,339 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 13 Oct 2013 | 1,463 | 632,211 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Oct 2013 | 2,621 | 633,674 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2013 | 150,000 | 359,600 | - | - | Employee Stock Option (right to buy) | |
| Anthony A. Ramos | Chief Accounting Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Aug 2013 | 25,000 | 40,665 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 22 Aug 2013 | 13,527 | 127,583 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Aug 2013 | 1,400 | 636,295 | - | - | Common Stock | |
| Anthony A. Ramos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 23 Jul 2013 | 83 | 15,665 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 19 Jul 2013 | 164 | 15,748 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 19 Jul 2013 | 164 | 15,912 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Jul 2013 | 1,471 | 637,695 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Jul 2013 | 2,635 | 639,166 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Jul 2013 | 1,097 | 173,134 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Jul 2013 | 592 | 172,542 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Jul 2013 | 1,317 | 174,231 | - | - | Common Stock $.01 par value | |
| George J. Morrow | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 May 2013 | 5,953 | 12,347 | - | - | Common Stock $.01 par value | |
| George J. Morrow | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2013 | 39,619 | 75,894 | - | - | Nonstatutory Stock Option (right to buy) | |
| Stephen A. Sherwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2013 | 40,176 | 40,176 | - | - | Nonstatutory Stock Option (right to buy) | |
| Stephen A. Sherwin | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 May 2013 | 7,003 | 7,003 | - | - | Common Stock $.01 par value | |
| Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2013 | 39,619 | 284,678 | - | - | Nonstatutory Stock Option (right to buy) | |
| Gary A. Lyons | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 May 2013 | 5,953 | 63,281 | - | - | Common Stock $.01 par value | |
| R. Gordon Douglas | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 May 2013 | 5,953 | 93,281 | - | - | Common Stock $.01 par value | |
| R. Gordon Douglas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2013 | 52,048 | 453,296 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert C. Merton | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 May 2013 | 5,953 | 75,781 | - | - | Common Stock $.01 par value | |
| Robert C. Merton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2013 | 39,619 | 298,741 | - | - | Nonstatutory Stock Option (right to buy) | |
| Richard M. Beleson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2013 | 40,176 | 40,176 | - | - | Nonstatutory Stock Option (right to buy) | |
| Richard M. Beleson | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 May 2013 | 7,003 | 7,078 | - | - | Common Stock $.01 par value | |
| Robert C. Merton | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2013 | 12,500 | 259,122 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert C. Merton | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2013 | 12,500 | 69,828 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 19 Apr 2013 | 164 | 16,158 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 19 Apr 2013 | 82 | 16,076 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 19 Apr 2013 | 164 | 16,322 | - | - | Common Stock $.01 par value | |
| Anthony A. Ramos | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2013 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Apr 2013 | 1,471 | 641,801 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Apr 2013 | 2,635 | 643,272 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Apr 2013 | 593 | 175,548 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Apr 2013 | 1,098 | 176,141 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Apr 2013 | 1,317 | 177,239 | - | - | Common Stock $.01 par value | |
| Jill M. Broadfoot | Sr Vice President, CFO, Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Apr 2013 | 38,121 | 145,649 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2013 | 35,250 | 2,012,250 | - | - | Employee Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Jan 2013 | 2,634 | 651,790 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Jan 2013 | 5,883 | 645,907 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Jan 2013 | 84,600 | 654,424 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2013 | 446,750 | 2,459,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Alain P. Rolland | Exec VP, Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2013 | 97,163 | 822,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Alain P. Rolland | Exec VP, Product Development | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Jan 2013 | 22,092 | 182,023 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Jan 2013 | 1,097 | 180,926 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Jan 2013 | 2,370 | 178,556 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2013 | 27,837 | 724,837 | - | - | Employee Stock Option (right to buy) | |
| Jill M. Broadfoot | Sr Vice President, CFO, Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2013 | 123,515 | 915,109 | - | - | Nonstatutory Stock Option (right to buy) | |
| Jill M. Broadfoot | Sr Vice President, CFO, Sec | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Jan 2013 | 27,060 | 234,935 | - | - | Common Stock $.01 par value | |
| Jill M. Broadfoot | Sr Vice President, CFO, Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Jan 2013 | 2,370 | 232,565 | - | - | Common Stock $.01 par value | |
| Jill M. Broadfoot | Sr Vice President, CFO, Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2013 | 29,594 | 791,594 | - | - | Employee Stock Option (right to buy) | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Jan 2013 | 1,316 | 160,699 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Jan 2013 | 768 | 159,931 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2012 | 5,000 | 569,824 | - | - | Common Stock | |
| Robert H. Campbell | None | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Oct 2012 | 37,500 | 179,122 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert H. Campbell | None | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Oct 2012 | 56,250 | 122,872 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert H. Campbell | None | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Oct 2012 | 12,500 | 216,622 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert H. Campbell | None | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Oct 2012 | 12,500 | 241,622 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert H. Campbell | None | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Oct 2012 | 12,500 | 229,122 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert H. Campbell | None | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Oct 2012 | 12,500 | 266,622 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert H. Campbell | None | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Oct 2012 | 6,000 | 6,000 | - | - | Common Stock | |
| Robert H. Campbell | None | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Oct 2012 | 20,000 | 46,622 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert H. Campbell | None | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Oct 2012 | 6,000 | 8,328 | - | - | Common Stock | |
| Robert H. Campbell | None | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Oct 2012 | 22,000 | 36,328 | - | - | Common Stock | |
| Robert H. Campbell | None | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Oct 2012 | 22,000 | 14,328 | - | - | Common Stock | |
| Robert H. Campbell | None | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Oct 2012 | 12,500 | 254,122 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert H. Campbell | None | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Oct 2012 | 20,000 | 20,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert H. Campbell | None | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Oct 2012 | 56,250 | 66,622 | - | - | Nonstatutory Stock Option (right to buy) | |
| George J. Morrow | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Oct 2012 | 6,394 | 6,394 | - | - | Common Stock $.01 par value | |
| George J. Morrow | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2012 | 36,275 | 36,275 | - | - | Nonstatutory Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Oct 2012 | 2,635 | 574,824 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Oct 2012 | 1,098 | 162,015 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Oct 2012 | 768 | 163,113 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Oct 2012 | 1,318 | 163,881 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Jul 2012 | 2,634 | 577,459 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Jul 2012 | 1,097 | 165,199 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Jul 2012 | 768 | 166,296 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Jul 2012 | 1,317 | 167,064 | - | - | Common Stock $.01 par value | |
| Robert H. Campbell | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 May 2012 | 7,328 | 58,328 | - | - | Common Stock $.01 par value | |
| Robert H. Campbell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2012 | 46,622 | 279,122 | - | - | Nonstatutory Stock Option (right to buy) | |
| Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2012 | 46,622 | 251,309 | - | - | Nonstatutory Stock Option (right to buy) | |
| Gary A. Lyons | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 May 2012 | 7,328 | 57,328 | - | - | Common Stock $.01 par value | |
| R. Gordon Douglas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2012 | 61,248 | 421,248 | - | - | Nonstatutory Stock Option (right to buy) | |
| R. Gordon Douglas | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 May 2012 | 7,328 | 87,328 | - | - | Common Stock $.01 par value | |
| Robert C. Merton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2012 | 46,622 | 271,622 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert C. Merton | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 May 2012 | 7,328 | 57,328 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Apr 2012 | 2,633 | 580,093 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Apr 2012 | 1,097 | 168,381 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Apr 2012 | 768 | 169,478 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Apr 2012 | 1,317 | 170,246 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2012 | 33,473 | 1,773,473 | - | - | Employee Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2012 | 328,527 | 2,102,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Jan 2012 | 67,000 | 582,726 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Jan 2012 | 27,000 | 171,563 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2012 | 29,875 | 639,875 | - | - | Employee Stock Option (right to buy) | |
| Alain P. Rolland | Exec VP, Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2012 | 117,125 | 757,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Jill M. Broadfoot | Sr Vice President, CFO, Sec | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Jan 2012 | 27,000 | 207,875 | - | - | Common Stock $.01 par value | |
| Jill M. Broadfoot | Sr Vice President, CFO, Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2012 | 29,875 | 644,875 | - | - | Employee Stock Option (right to buy) | |
| Jill M. Broadfoot | Sr Vice President, CFO, Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2012 | 117,125 | 762,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Jan 2012 | 2,635 | 515,726 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Jan 2012 | 1,098 | 144,563 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Jan 2012 | 5,269 | 146,429 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Jan 2012 | 768 | 145,661 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Jan 2012 | 109 | 151,698 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Oct 2011 | 2,632 | 518,361 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Oct 2011 | 767 | 152,903 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Oct 2011 | 1,096 | 151,807 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Oct 2011 | 109 | 153,670 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Jul 2011 | 2,636 | 520,993 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Jul 2011 | 768 | 154,877 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Jul 2011 | 1,098 | 153,779 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Jul 2011 | 109 | 155,645 | - | - | Common Stock $.01 par value | |
| Robert H. Campbell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2011 | 56,250 | 232,500 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert H. Campbell | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 May 2011 | 18,750 | 51,000 | - | - | Common Stock $.01 par value | |
| Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2011 | 56,250 | 210,937 | - | - | Nonstatutory Stock Option (right to buy) | |
| Gary A. Lyons | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 May 2011 | 18,750 | 50,000 | - | - | Common Stock $.01 par value | |
| R. Gordon Douglas | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 May 2011 | 30,000 | 80,000 | - | - | Common Stock $.01 par value | |
| R. Gordon Douglas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2011 | 90,000 | 380,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert C. Merton | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 May 2011 | 18,750 | 50,000 | - | - | Common Stock $.01 par value | |
| Robert C. Merton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2011 | 56,250 | 245,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Apr 2011 | 2,634 | 523,629 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Apr 2011 | 768 | 156,851 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Apr 2011 | 1,097 | 155,754 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Apr 2011 | 109 | 157,619 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Feb 2011 | 500 | 526,263 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 21 Jan 2011 | 500 | 525,763 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Jan 2011 | 1,000 | 525,263 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 Jan 2011 | 150,000 | 534,785 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Jan 2011 | 10,522 | 524,263 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2011 | 38,370 | 1,328,370 | - | - | Employee Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2011 | 411,630 | 1,740,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Alain P. Rolland | Exec VP, Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2011 | 42,777 | 472,777 | - | - | Employee Stock Option (right to buy) | |
| Alain P. Rolland | Exec VP, Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2011 | 137,223 | 610,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Jan 2011 | 4,384 | 157,727 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 Jan 2011 | 60,000 | 162,877 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Jan 2011 | 766 | 162,111 | - | - | Common Stock $.01 par value | |
| Jill M. Broadfoot | Sr Vice President, CFO, Sec | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 Jan 2011 | 60,000 | 180,875 | - | - | Common Stock $.01 par value | |
| Jill M. Broadfoot | Sr Vice President, CFO, Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2011 | 42,777 | 477,777 | - | - | Employee Stock Option (right to buy) | |
| Jill M. Broadfoot | Sr Vice President, CFO, Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2011 | 137,223 | 615,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 05 Jan 2011 | 657 | 384,785 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Jan 2011 | 109 | 103,008 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Jan 2011 | 131 | 102,877 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Dec 2010 | 1,000 | 385,442 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Dec 2010 | 1,000 | 384,442 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Nov 2010 | 1,000 | 383,442 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Oct 2010 | 767 | 103,118 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 05 Oct 2010 | 657 | 382,442 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Oct 2010 | 109 | 104,016 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Oct 2010 | 131 | 103,885 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Jul 2010 | 768 | 104,125 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 05 Jul 2010 | 658 | 383,099 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Jul 2010 | 109 | 105,024 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Jul 2010 | 131 | 104,893 | - | - | Common Stock $.01 par value | |
| Robert H. Campbell | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 May 2010 | 18,750 | 32,250 | - | - | Common Stock $.01 par value | |
| Robert H. Campbell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2010 | 56,250 | 176,250 | - | - | Nonstatutory Stock Option (right to buy) | |
| Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2010 | 56,250 | 193,750 | - | - | Nonstatutory Stock Option (right to buy) | |
| Gary A. Lyons | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 May 2010 | 18,750 | 31,250 | - | - | Common Stock $.01 par value | |
| R. Gordon Douglas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2010 | 90,000 | 310,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| R. Gordon Douglas | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 May 2010 | 30,000 | 50,000 | - | - | Common Stock $.01 par value | |
| Robert C. Merton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2010 | 56,250 | 188,750 | - | - | Nonstatutory Stock Option (right to buy) | |
| Robert C. Merton | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 May 2010 | 18,750 | 31,250 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Apr 2010 | 768 | 105,133 | - | - | Common Stock $.01 par value | |
| Vijay B. Samant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 05 Apr 2010 | 658 | 383,757 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Apr 2010 | 109 | 106,032 | - | - | Common Stock $.01 par value | |
| Alain P. Rolland | Exec VP, Product Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Apr 2010 | 131 | 105,901 | - | - | Common Stock $.01 par value |